It is unclear yet that why CCR5 and CCL5 are down-regulated in CHI patients but genetical parameters such as CCR5 D 32 mutation and polymorphisms within CCR5 and CCL5 genes as well as epigenetical parameters may affect their expression (14, 20, 21). Here, CCL5 is linked to congenital isolated hyperinsulinism.